Mera Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRPI research report →
About the company
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts.
- CEO
- Edmundo Gonzalez
- IPO
- 1995
- Employees
- 74
- HQ
- Las Vegas, NV, US
Price Chart
- Market Cap
- $55.73K
- P/E
- -10000.00
- P/S
- 0.00
- P/B
- -1875.00
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 18.75%
- Revenue
- $0 · 0.00%
- Net Income
- $-5.58 · 0.00%
- EPS
- $0.00 · 0.00%
- Op Income
- $-5.58
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 43.34
- Avg Volume
- 1.97K
Get TickerSpark's AI analysis on MRPI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MRPI coverage
Recent articles, reports, and earnings notes.
No research on MRPI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRPI report →Similar companies
Peers in the same neighborhood.